B855 Pill - red round
Pill with imprint B855 is Red, Round and has been identified as Repaglinide 2 mg. It is supplied by Breckenridge Pharmaceutical, Inc.
Repaglinide is used in the treatment of Type 2 Diabetes and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B855
Repaglinide
- Imprint
- B855
- Strength
- 2 mg
- Color
- Red
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Meglitinides
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC)
- 51991-0855 (Discontinued)
- Inactive Ingredients
-
microcrystalline cellulose,
polacrilin potassium,
povidone k30,
magnesium stearate,
poloxamer 407,
calcium phosphate dibasic anhydrous,
ferric oxide red
Note: Inactive ingredients may vary.
Related images for "B855"
More about repaglinide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: meglitinides
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.